ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

ngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½ÔºÍõÑ©¾§ÍŶÓÕ¹ÏÖ³¦µÀ¾úÈºÒÆÖ²ÎªÅÁ½ðÉ­²¡ÖÎÁÆ´øÀ´ÐÂÍ»ÆÆ

¸å¼þȪԴ£ºÁ¥ÊôµÚÒ»Ò½Ôº ±à¼­£ºÓàæÃ ÉóºË£ºËïÒ«±ó ÔĶÁÁ¿£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¿µ¾þÃù£©¿ËÈÕ£¬£¬Á¥ÊôµÚÒ»Ò½ÔºÍõÑ©¾§½ÌÊÚÍŶÓÔÚ¹ú¼ÊÆÚ¿¯Signal Transduction and Targeted Therapy½ÒÏþÑо¿ÂÛÎÄ¡£¡£¸ÃÑо¿¿ªÕ¹ÁËÒ»ÏîÑϽ÷µÄ¢òÆÚËæ»ú˫ä±ÈÕÕÁÙ´²ÊÔÑé¡£¡£Á¢ÒìÐԵؽÓÄɾ­ÄÚ¾µ³¦µÀÖ²¹ÜÊõ¾ÙÐо«×¼µÝËÍ£¬£¬¶Ô72ÃûÎ´Ôø½ÓÊܹý¶à°Í°·ÄÜÒ©ÎïÖÎÁƵÄPD»¼Õߣ¬£¬ÊµÑéÁËΪÆÚ35ÖÜ¡¢¡¢¹²Èý¸öÖÜÆÚµÄ·à¾úÒÆÖ²£¨FMT£©¸ÉÔ¤¡£¡£

Ñо¿Ð§¹ûÏÔʾÖÎÁÆ35Öܺ󣬣¬½ÓÊÜ¿µ½¡¹©ÌåFMT£¨dFMT£©»¼ÕßÔ˶¯¹¦Ð§ÆÀ·Ö£¨UPDRS-¢ó£©½Ï»ùÏ߯½¾ùÏÔÖø¸ÄÉÆ3.8·Ö£¬£¬¶ø×ÔÌåFMT£¨aFMT£©±ÈÕÕ×éÏÕЩÎÞת±ä£¬£¬×é¼äµ÷½âºó²î±ð3.9·Ö£¬£¬Í³¼ÆÑ§ÒâÒåÏÔÖø¡£¡£dFMT×éÖÐ45.5%»¼ÕßµÖ´ï¡°×îСÁÙ´²Ö÷Òª²î±ðãÐÖµ£¨MCID£©¡±£¬£¬ÏÔÖø¸ßÓÚ±ÈÕÕ×éµÄ21.2%¡£¡£

7C78A24B5ACD170B8FA662427E0_D929BA74_37F40

PD»¼Õß·à±ã΢ÉúÎïȺ×é³ÉÓë¶à°Í°·ÆÊÎö´úл¼°Á×Ëữ¦Á-synÖ®¼äµÄÏà¹ØÐÔ

½ÓÄɹú¼ÊͨÓñãÃØÆÀ·ÖÁ¿±í£¨CSS£©ÆÀ¹À£¬£¬dFMT×黼Õ߯À·Öƽ¾ùϽµ6.5·Ö£¬£¬Ô¶³¬±ÈÕÕ×é¡£¡£Ô˶¯¹¦Ð§µÄ¸ÄÉÆÓëÏÂÏû»¯µÀÖ¢×´µÄ»º½â±£´æ¹ØÁª£¬£¬Îª¡°³¦-ÄÔÖᡱµÄË«Ïò»¥¶¯ÌṩҪº¦µÄÁÙ´²Ö¤¾Ý¡£¡£ÖÎÁƺó»¼Õß³¦µÀ¾úȺ½á¹¹Ïò¿µ½¡¹©Ì寫Ïò±¬·¢×ª±ä£¬£¬ÓëPD³¦µÀÑ×Ö¢Ç×½üÏà¹ØµÄEscherichia-Shigella¾úÊôƷò½µµÍ¡£¡£ÕâÒ»Òªº¦¾úȺת±äÓ뻼Õ᳦߽»î¼ì×éÖ¯ÖÐÁ×Ëữ¦Á-syn²¡ÀíȺ¼¯µÄïÔÌ­³ÊÏÔÖøÕýÏà¹Ø¡£¡£

³¦µÀð¤Ä¤ÆÁÕϹ¦Ð§»ñµÃÐÞ¸´ÖÎÁƺó»¼Õß·à±ãÖжà°Í°·¼°ÆäÖ÷Òª´úлÎïDOPACµÄˮƽÏÔÖøÉý¸ß£¬£¬ÌáÐѾúÈºÖØËÜ¿ÉÄÜÓ°ÏìÁËËÞÖ÷ÍâÖÜÉñ¾­µÝÖÊ´úлÇéÐΡ£¡£ÖÎÁÆÀú³ÌÖÐÎÞÈκÎÑÏÖØ²»Á¼ÊÂÎñ±¬·¢¡£¡£

ÕâÏîÑо¿ÔÚ³õÖÎPDÈËȺÖУ¬£¬Í¨¹ý¸ßÆ·¼¶µÄÑо¿Éè¼Æ£¬£¬ÏµÍ³Ö¤ÊµÁËFMTÇå¾²ÐÔ¼°ÓÐÓÃÐÔ£¬£¬´Ó¶à²ãÃæÌṩÁËÖ§³Ö¡°³¦-ÄÔÖᡱ×÷ΪÖÎÁưеãµÄÖ¤¾Ý£¬£¬Îª¿ª·¢¸Ä±ä¼²²¡Àú³ÌµÄ·ÇÒ©ÎïÁÆ·¨¿ª·¢ÁËÐÂÆ«Ïò¡£¡£

ÂÛÎÄÁ´½Ó£º

https://www.nature.com/articles/s41392-026-02604-9

¡¾ÍøÕ¾µØÍ¼¡¿